About MegaPro Biomedical
MegaPro Biomedical is a company based in Hsinchu (Taiwan) founded in 2014.. The company has 27 employees as of December 31, 2024. MegaPro Biomedical operates in a competitive market with competitors including Freeline, Imbed Biosciences, Disc Medicine, Alentis Therapeutics and Keros Therapeutics, among others.
- Headquarter Hsinchu, Taiwan
- Employees 27 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Megapro Biomedical Co., Ltd.
-
Annual Revenue
$0 (USD)-22.22as on Dec 31, 2024
-
Net Profit
$0 (USD)-28.61as on Dec 31, 2024
-
EBITDA
$0 (USD)-31.58as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
27
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MegaPro Biomedical
MegaPro Biomedical is a publicly listed company on the TPEX with ticker symbol 6827 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of MegaPro Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by MegaPro Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MegaPro Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Megapro Biomedical Comparisons
Competitors of MegaPro Biomedical
MegaPro Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freeline, Imbed Biosciences, Disc Medicine, Alentis Therapeutics and Keros Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of hematologic diseases
|
|
| domain | founded_year | HQ Location |
Therapies for fibrosis, cirrhosis, and liver cancer are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed to treat hematologic and musculoskeletal disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MegaPro Biomedical
When was MegaPro Biomedical founded?
MegaPro Biomedical was founded in 2014.
Where is MegaPro Biomedical located?
MegaPro Biomedical is headquartered in Hsinchu, Taiwan.
Who is the current CEO of MegaPro Biomedical?
Jassy Wang is the current CEO of MegaPro Biomedical.
How many employees does MegaPro Biomedical have?
As of Dec 31, 2024, the latest employee count at MegaPro Biomedical is 27.
What does MegaPro Biomedical do?
MegaPro Biomedical was founded in 2014 in Hsinchu, Taiwan, within the biotechnology sector. Proprietary PEGylated iron oxide nanoparticles, branded as IOP Injection, are developed as a contrast agent for magnetic resonance imaging. Additionally, this non-sugar-based intravenous iron formulation is targeted for iron-deficiency anemia and hepatocellular carcinoma treatments. Operations center on advancing these niche pharmaceutical applications through research and development.
Who are the top competitors of MegaPro Biomedical?
MegaPro Biomedical's top competitors include Imbed Biosciences, Keros Therapeutics and Disc Medicine.
Is MegaPro Biomedical publicly traded?
Yes, MegaPro Biomedical is publicly traded on TPEX under the ticker symbol 6827.
What is MegaPro Biomedical's ticker symbol?
The ticker symbol of MegaPro Biomedical is 6827 on TPEX.